AHCC - A Novel Approach To The Treatment Of Common Illness

Dr. Pescatore to Present at International AHCC Symposium

RYE, N.Y., August 13, 2001 — Dr. Fred Pescatore, M.D., M.P.H., of the Centers For Integrative and Complementary Medicine, and medical director for the AHCC (Active Hexose Correlated Compound) Research Association, is scheduled to speak on how AHCC is a novel approach to the treatment of common illness at the 9th International Symposium of the AHCC Research Association in Sapporo, Japan, August 18-19, 2001.

“Diseases originate with a weakened immune system,” stated Pescatore. “When it malfunctions, it can unleash a torrent of diseases, from common illnesses to cancer or hepatitis. When your immune system is strong, you can withstand most illnesses and prevent the onset of disease.”

Building upon 14 years of patient success in Japan, the Japanese nutritional supplement used to boost the immune system is making its way into U.S. hospitals and medical clinics.

Dr. Pescatore’s daily practice consists of treating patients with health problems ranging from AIDS to cancer to the more daily ailments with a combination of both alternative and conventional medicines focusing on building immunity.

“AHCC is increasingly being used in my clinical practice and many others as an efficacious nutritional supplement for those with cancer, hepatitis and other ailments involving immune dysfunction,” noted Pescatore.

According to industry analysts in Japan, over 700 hospitals and medical clinics recommend AHCC to patients in that country as part of an immune enhancement maintenance regimen, creating a $150 million (USD) industry.

AHCC has been the subject of some 325 clinical studies conducted at prestigious Japanese institutions such as Hokkaido University, Kyorin University and Teikyo University. Currently 35,000 individuals worldwide use the nutritional supplement monthly.

Approximately 350 medical doctors from around the world are scheduled to attend the 9th International Symposium of AHCC Research Association. The focus of the Symposium is to discuss new AHCC clinical research studies and developments. For more information and updates from the Symposium visit www.ahccresearch.com.

# # #

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.